Inventor · disambiguated record
Silvia Gatti Mcarthur
Also filed as: MCARTHUR SILVIA G · MCARTHUR SILVIA GATTI
7 granted patents·5 pending applications·26 citations·filing 2004–2024
80Inventor score
Top patents by PatentIndex Score
12 records- 0187US7534891B2Quinoline derivatives as H3R inverse agonistsHOFFMANN LA ROCHE·Filed 2005·Granted May 19, 2009·12 cites·20 claims
- 0283US2025017937A1Mglu2/3 antagonists for the treatment of intellectual disabilitiesHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 0382US7504404B2Compounds as metabotropic glutamate receptor antagonistsHOFFMANN LA ROCHE·Filed 2006·Granted Mar 17, 2009·5 cites·14 claims
- 0480US7238808B2Acetylenyl-pyrazolo-pyrimidine derivativesHOFFMANN LA ROCHE·Filed 2006·Granted Jul 3, 2007·3 cites·42 claims
- 0574US7361682B2Indole derivatives as H3 inverse agonistsHOFFMANN LA ROCHE·Filed 2005·Granted Apr 22, 2008·2 cites·26 claims
- 0667US7235547B2Pharmaceutical composition comprising an AChE inhibitor and a mGluR2 antagonistHOFFMANN LA ROCHE·Filed 2004·Granted Jun 26, 2007·4 cites·19 claims
- 0760US2019343839A1Mglu2/3 antagonists for the treatment of intellectual disabilitiesHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 0858US2018235971A1Mglu2/3 antagonists for the treatment of intellectual disabilitiesHOFFMANN LA ROCHE·Filed 2018·Application pending·0 cites
- 0956US7608617B2Naphthaline derivatives as H3 inverse agonistsHOFFMANN LA ROCHE·Filed 2007·Granted Oct 27, 2009·0 cites·27 claims
- 1053US2017035767A1Mglu2/3 antagonists for the treatment of intellectual disabilitiesHOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
- 1151US7259158B2Naphthaline derivatives as H3 inverse agonistsHOFFMANN LA ROCHE·Filed 2005·Granted Aug 21, 2007·0 cites·12 claims
- 1241US2006173048A1Imidazole derivativesMCARTHUR SILVIA G·Filed 2006·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →